Sigvotatug is a fully human IgG1 kappa monoclonal antibody targeting integrin beta6 (ITGB6). It can serve as the antibody component in the development of Sigvotatug vedotin, an antibody-drug conjugate (ADC) designed to selectively target integrin alphavbeta6-positive tumor cells through a highly specific, engineered antibody framework.
Reinheit:
95.00%
CAS Nummer:
[2764774-90-3]
Target-Kategorie:
Integrin
T9901A-506
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
